GenoLogics Completes Additional Financing To Accelerate Translational Research Informatics Growth

Tools

GenoLogics Completes Additional Financing To Accelerate Translational Research Informatics Growth

For Immediate Release
VICTORIA, BC Canada/EWORLDWIRE/Feb. 25, 2009 --- GenoLogics, the leading provider of informatics solutions for translational research, today announced it has completed $5 million in financing, which will be applied towards ongoing expansion plans.

The latest round of financing was led by OVP Venture Partners of Seattle with support from Growth Works and Yaletown Venture Partners of Vancouver. The funds will be used to accelerate development and global deployment of an end-to-end informatics solution for organizations pursuing translational research initiatives.

"We feel positive that the growth GenoLogics has experienced will continue as the company expands its footprint in the life sciences software market," said Chad Waite, Managing Director at OVP Venture Partners. "We've already seen GenoLogics make significant inroads by establishing collaborative partnerships with leading organizations that are looking for ways to achieve their translational research outcomes."

Last year GenoLogics announced a new product suite for biorepositories and biomedical informatics to help customers better manage their clinical information. GenoLogics has developed this product suite in collaboration with the Fred Hutchinson Cancer Center, Windber Research Institute and the University of Texas Medical Branch. When the biomedical products are deployed in combination with the GenoLogics research informatics solutions, clients have a comprehensive bench-to-bedside informatics platform to enable their translational research initiatives.

"Over the past year, we've invested in enhancing the capabilities our informatics platform to integrate data from both the clinical and research domains, providing our clients with an end-to-end translational research solution," said Michael Ball, CEO for GenoLogics. "The additional funding will allow us to accelerate deployment of our biomedical informatics product suite, as well as expand our sales and support infrastructure to sustain the rapid increase we are seeing in customer adoption."

About GenoLogics

GenoLogics is the leading provider of informatics solutions for translational research, spanning both the discovery and biomedical research domains. Science-purposed modules for discovery research are complemented by a highly configurable, integrating lab informatics platform that is scalable to service many labs and sciences across an organization. The Biomedical Informatics product suite allows labs to track and manage their biospecimen and clinical annotations data, while aggregating results with our Research Informatics solution for a holistic view. For more information, please visit http://www.genologics.com.

GenoLogics Contact:
Bobbi Leach
Manager, Marketing Communications
250.483.7063
roberta.leach@genologics.com

   HTML: http://www.eworldwire.com/pressreleases/19402
   MOBILE: http://e4mobile.com/view_release.php?id=19402
   PDF: http://www.eworldwire.com/pdf/19402.pdf
   ONLINE NEWSROOM: http://www.eworldwire.com/newsroom/313760.htm
   NEWSROOM RSS FEED: http://newsroom.eworldwire.com/xml/newsrooms/313760.xml
   LOGO: http://www.eworldwire.com/newsroom/313760.htm

CONTACT:
Bobbi Leach
GenoLogics
4464 Markham
Victoria, BC V8Z 7X8
PHONE. 250.483.7063
EMAIL: roberta.leach@genologics.com

KEYWORDS: life sciences software, LIMS software, genomics software, proteomics software, biomedical informatics software, data management software, systems biology software, translational research software, Genologics, LIMS, lab and data management, financing, life sciences research, international business, genetics, gene sequencing, technology